Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants
{{output}}
Small-molecule-binding proteins can neutralize toxins and cytotoxic drugs, but their development is hindered by unpredictable in vivo behaviour and the poor immunogenicity of small molecules, which limits antibody-based approaches. Here we present a strategy t... ...
